No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Alnylam, Lilly, AstraZeneca Among Best Performing Pharmas, Biotechs in Q2
Super Micro Computer Led the S&P in the First Half. Walgreens Was the Top Loser
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
J&J Talc Claimants Lose Bid to Block Bankruptcy Bid
J&J Reports Positive Phase 3 Data for Nipocalimab for Neuromuscular Disease
Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial